- Forums
- ASX - By Stock
- Ann: Positive Interim Data from ATH434-202 Phase 2 Clinical Trial
Totally agree.
-
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add ATH (ASX) to my watchlist
|
|||||
Last
0.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $21.28M |
Open | High | Low | Value | Volume |
0.4¢ | 0.4¢ | 0.4¢ | $4 | 935 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
116 | 101983807 | 0.4¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.5¢ | 21100397 | 13 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
116 | 101983807 | 0.004 |
59 | 47469432 | 0.003 |
20 | 34675515 | 0.002 |
15 | 104320101 | 0.001 |
0 | 0 | 0.000 |
Price($) | Vol. | No. |
---|---|---|
0.005 | 21100397 | 13 |
0.006 | 23547365 | 23 |
0.007 | 27734705 | 25 |
0.008 | 29046938 | 31 |
0.009 | 18748789 | 13 |
Last trade - 10.47am 23/07/2024 (20 minute delay) ? |
Featured News
ATH (ASX) Chart |
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, CEO & MD
Charles Armstrong
CEO & MD
Previous Video
Next Video
SPONSORED BY The Market Online